Drugs Made In America Acquisition II Corp. (DMII)
10.22
+0.02
(+0.15%)
USD |
NASDAQ |
Nov 04, 16:00
Drugs Made In America Acquisition II Net Income (Quarterly) : 4.396M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 4.396M |
| March 31, 2026 | 4.338M |
| December 31, 2025 | 4.331M |
| September 30, 2025 | -0.0462M |
| Date | Value |
|---|---|
| June 30, 2025 | -0.0381M |
| March 31, 2025 | -0.0593M |
| September 30, 2024 | -0.0417M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Acme United Corp. | 3.435M |
| American Shared Hospital Services | -0.998M |
| Avalon Holdings Corp. | 0.809M |
| Flanigan's Enterprises, Inc. | 3.46M |
| Bar Harbor Bankshares | 16.09M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | -4.396M |
| EPS Diluted (Quarterly) | 0.069 |
| Enterprise Value | 651.61M |
| Earnings Yield | 1.99% |
| Normalized Earnings Yield | 1.932 |